Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
3.500
-0.250 (-6.67%)
At close: Nov 13, 2026, 4:00 PM EST
3.410
-0.090 (-2.57%)
After-hours: Nov 13, 2026, 4:41 PM EST
Starling Oncology Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Starling Oncology stock has a consensus rating of "Strong Buy" and an average price target of $9.25. The average 1-year stock price forecast is 164.29% higher than the current stock price, while the lowest is $8.00 (+128.57%) and the highest is $10 (+185.71%).
Price Target: $9.25 (+164.29%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Starling Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Maintains $10 | Buy | Maintains | $10 | +185.71% | Nov 9, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +185.71% | Nov 6, 2026 |
| Lake Street | Lake Street | Buy Maintains $10 → $8 | Buy | Maintains | $10 → $8 | +128.57% | Nov 6, 2026 |
| Needham | Needham | Buy Reiterates $7 → $9 | Buy | Reiterates | $7 → $9 | +157.14% | Oct 14, 2026 |
Financial Forecast
Revenue This Year
656.39M
from 502.73M
Increased by 30.57%
Revenue Next Year
875.06M
from 656.39M
Increased by 33.31%
EPS This Year
n/a
EPS Next Year
n/a